Found: 13
Select item for more details and to access through your institution.
Management and Risk Factors for Pleural Effusion in Japanese Patients with Chronic Myeloid Leukemia Treated with First-line Dasatinib in Real-world Clinical Practice.
- Published in:
- Internal Medicine, 2023, v. 62, n. 22, p. 3299, doi. 10.2169/internalmedicine.1611-23
- By:
- Publication type:
- Article
Refractory Primary Vitreoretinal Lymphoma Involving the Spinal Cord with a Temporary Complete Response to Tirabrutinib.
- Published in:
- Internal Medicine, 2023, v. 62, n. 3, p. 459, doi. 10.2169/internalmedicine.9591-22
- By:
- Publication type:
- Article
Clinical Efficacy and Safety of First-Line Dasatinib Therapy and the Relevance of Velocity of BCR-ABL1 Transcript Decline for Achievement of Molecular Responses in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia: Report from the Juntendo Yamanashi Cooperative Study Group
- Published in:
- Oncology, 2018, v. 94, n. 2, p. 85, doi. 10.1159/000481945
- By:
- Publication type:
- Article
Changes in chronic myeloid leukemia treatment modalities and outcomes after introduction of second-generation tyrosine kinase inhibitors as first-line therapy: a multi-institutional retrospective study by the CML Cooperative Study Group.
- Published in:
- International Journal of Hematology, 2024, v. 120, n. 1, p. 60, doi. 10.1007/s12185-024-03758-4
- By:
- Publication type:
- Article
Clinical management of second-generation tyrosine kinase inhibitor therapy in patients with newly diagnosed chronic myeloid leukemia in the chronic phase, focusing on age and dose effects.
- Published in:
- International Journal of Hematology, 2023, v. 118, n. 2, p. 210, doi. 10.1007/s12185-023-03606-x
- By:
- Publication type:
- Article
Bortezomib maintenance therapy in transplant-ineligible myeloma patients who plateaued after bortezomib-based induction therapy: a multicenter phase II clinical trial.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Gastric invasion of multiple myeloma presenting as gastrointestinal bleeding.
- Published in:
- 2015
- By:
- Publication type:
- Letter
Cutaneous invasion of leukemia cells during blastic transformation in a post polycythemia vera myelofibrosis patient.
- Published in:
- 2014
- By:
- Publication type:
- Letter
Development of rapidly fatal TAFRO syndrome-like features in a patient with essential thrombocythemia.
- Published in:
- Journal of Clinical & Experimental Hematopathology, 2023, v. 63, n. 1, p. 32, doi. 10.3960/jslrt.22029
- By:
- Publication type:
- Article
Role of TGF-beta1 and TNF-alpha1 produced by neoplastic cells in the pathogenesis of fibrosis in patients with hematologic neoplasms.
- Published in:
- Journal of Clinical & Experimental Hematopathology, 2023, v. 63, n. 2, p. 83, doi. 10.3960/jslrt.22044
- By:
- Publication type:
- Article
Factors Associated With Survival in Patients With End-of-Life Hematological Malignancies Who Received Chemotherapy: A Retrospective Single-Institution Study.
- Published in:
- American Journal of Hospice & Palliative Medicine, 2023, v. 40, n. 8, p. 812, doi. 10.1177/10499091221142502
- By:
- Publication type:
- Article
Possible New Histological Prognostic Index for Large B-Cell Lymphoma.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 19, p. 6324, doi. 10.3390/jcm12196324
- By:
- Publication type:
- Article
Extranodal NK/T-cell lymphoma, nasal type of the uterine cervix: A case report.
- Published in:
- Diagnostic Cytopathology, 2016, v. 44, n. 5, p. 430, doi. 10.1002/dc.23439
- By:
- Publication type:
- Article